Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now displayed, replacing the previous Revision: v3.5.3. This reflects a small update to the page rendering without changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-05-15T05:47:40.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a maintenance or release update to the hosting platform rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:59:03.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The site revision changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:35.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:13:00.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:39.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Status updated to Terminated with <75% participation and related dates; an Informed Consent Form PDF is now listed under Study Documents (M.D. Anderson Cancer Center).
    Difference
    1%
    Check dated 2026-02-25T18:25:42.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.